Arthritis as a Manifestation of Systemic Disease Treatment & Management

  • Author: Ritu Khurana, MD; Chief Editor: Herbert S Diamond, MD   more...
 
Updated: Dec 15, 2010
 

Medical Care

A complete discussion of the medical therapy for each of these diseases that may have arthritis as a manifestation may be found in the article concerning that particular disease. See Hypothyroidism; Hyperparathyroidism; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Cushing Syndrome; Acromegaly; Hypercholesterolemia, Familial; Hemochromatosis; and Sarcoidosis.

  • Hypothyroidism: This is easily treated with thyroid hormone by mouth, except under life-threatening circumstances (ie, myxedema coma), when an intravenous route can be used.
  • Diabetes: This illness is managed medically with oral agents, like sulfonylureas, metformin, thiazolidinediones, as well as with parenteral insulin, with stress on the importance of dietary modification and weight loss.
  • Acromegaly: This disorder is managed medically with a regimen that includes octreotide, pegvisomant, or bromocriptine. Initially, most patients are treated surgically.
  • Hyperlipidemia: Familial hypercholesterolemia is managed with a hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitor, which is the mainstay of therapy and may be used in combination with other agents.
  • Hemochromatosis: Patients are treated by phlebotomy in order to reduce the level of total body iron to the reference range. Therapy can be monitored by following the patient's ferritin levels. Therapy with phlebotomy has little effect on the clinical and radiologic progression of arthropathy.
  • Sarcoidosis: Early or late sarcoid arthritis responds to nonsteroidal anti-inflammatory drugs.
    • Colchicine also can be used for acute sarcoid arthritis.
    • Occasionally for severe acute arthritis with or without erythema nodosum, a course of corticosteroids provides rapid relief of pain and inflammation.
    • Mucocutaneous sarcoidosis often improves with antimalarial agents.
    • Corticosteroids are used to suppress potentially serious inflammatory reactions such as uveitis, severe lung disease, neurosarcoidosis, and severe sarcoidosis of other organs.
    • Methotrexate can be used as a steroid-sparing agent in patients with chronic disease.
Next

Surgical Care

  • Hyperparathyroidism
    • Treatment for an adenoma is surgical resection by an experienced surgeon.
    • Hyperplasia is also managed surgically, most commonly with a 3-and-one-half gland resection, sometimes followed with the implantation of a small portion of 1 gland.
    • In the hands of an experienced and knowledgeable surgeon, parathyroidectomy is curative in 98% of cases and has a low (< 1%) instance of permanent hypoparathyroidism or laryngeal nerve injury.
    • Data are clear that less experienced surgeons have substantially lower cure rates (approximately 75%) and higher complication rates.
  • Cushing syndrome: Most patients are cured with resection of the pituitary tumor via transsphenoidal surgery.
  • Acromegaly
    • The primary therapy of this disease remains surgical resection of the tumor.
    • Unfortunately, this procedure frequently does not result in a permanent cure. Many patients not cured by surgery go on to receive radiation therapy targeting the pituitary.
Previous
Next

Consultations

  • Hypothyroidism and diabetes usually do not mandate a consultation.
  • Hyperparathyroidism
    • Consultation with an endocrinologist may be useful to ensure the diagnosis is correct.
    • Consultation with a surgeon experienced in neck exploration is essential.
  • Cushing disease
    • An endocrinologist likely will be needed to guide the patient through the maze of diagnostic tests that are required. These include provocative testing, such as high-dose dexamethasone suppression testing and petrosal sinus sampling.
    • An interventional radiologist experienced in petrosal sampling likely will be needed.
    • If pituitary-dependent Cushing disease is confirmed, consultation with a neurosurgeon experienced in transsphenoidal hypophysectomy is indicated.
  • Acromegaly
    • In many patients, provocative testing of growth hormone will be required. An endocrinologist should supervise this testing.
    • Surgical therapy requires a neurosurgeon who is an expert in pituitary surgery.
    • Late in the disease, joint problems can cause significant morbidity, and consultation with a rheumatologist or orthopedic surgeon may be needed.
  • Hyperlipidemia: In poorly controlled hyperlipidemia, especially in patients requiring multiple drugs, consultation with an endocrinologist or other lipidologist may be appropriate.
  • Hemochromatosis
    • Many patients require a liver biopsy obtained by a gastroenterologist.
    • Prolonged phlebotomy is required, during which several dozen units of blood are removed over months to years. Such specialized therapy should be monitored by a gastroenterologist or hematologist with experience in this procedure.
  • Sarcoidosis
    • A pulmonologist should be consulted when chest findings are abnormal. Patients may need bronchoscopic biopsy or mediastinoscopy for definitive diagnosis.
    • A rheumatologist may be consulted for the management of joint disease.
    • Patients need a thorough eye examination by an ophthalmologist to determine whether evidence of uveitis is present.
Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Ritu Khurana, MD  Chief of Rheumatology, Crozer Chester Medical Center

Ritu Khurana, MD is a member of the following medical societies: American College of Physicians, American College of Rheumatology, and International Society for Clinical Densitometry

Disclosure: Nothing to disclose.

Specialty Editor Board

Kristine M Lohr, MD, MS  Professor, Department of Internal Medicine, Center for the Advancement of Women's Health and Division of Rheumatology, Director, Rheumatology Training Program, University of Kentucky College of Medicine

Kristine M Lohr, MD, MS is a member of the following medical societies: American College of Physicians, American College of Rheumatology, and American Medical Women's Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Senior Pharmacy Editor, eMedicine

Disclosure: eMedicine Salary Employment

Lawrence H Brent, MD  Associate Professor of Medicine, Thomas Jefferson University; Chair, Program Director, Department of Medicine, Division of Rheumatology, Albert Einstein Medical Center

Lawrence H Brent, MD is a member of the following medical societies: American Association for the Advancement of Science, American Association of Immunologists, American College of Physicians, and American College of Rheumatology

Disclosure: Genentech Honoraria Speaking and teaching; Genentech Grant/research funds Other; Amgen Honoraria Speaking and teaching; Pfizer Honoraria Speaking and teaching; Abbott Immunology Honoraria Speaking and teaching; Takeda Honoraria Speaking and teaching; UCB Speaking and teaching; Omnicare Consulting fee Consulting; Centocor Consulting fee Consulting

Alex J Mechaber, MD, FACP  Senior Associate Dean for Undergraduate Medical Education, Associate Professor of Medicine, University of Miami Miller School of Medicine

Alex J Mechaber, MD, FACP is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians-American Society of Internal Medicine, and Society of General Internal Medicine

Disclosure: Nothing to disclose.

Chief Editor

Herbert S Diamond, MD  Professor of Medicine, Temple University School of Medicine; Chairman Emeritus, Department of Internal Medicine, Western Pennsylvania Hospital

Herbert S Diamond, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, American College of Rheumatology, American Medical Association, and Phi Beta Kappa

Disclosure: Stock ownership in multiple Pharmaceutical companies Ownership interest Other

References
  1. Helfand M, Crapo LM. Screening for thyroid disease. Ann Intern Med. Jun 1 1990;112(11):840-9. [Medline].

  2. Schmitt B, Golub RM, Green R. Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: systematic review for the American College of Physicians. Ann Intern Med. Oct 4 2005;143(7):522-36. [Medline].

  3. Cagliero E, Apruzzese W, Perlmutter GS, Nathan DM. Musculoskeletal disorders of the hand and shoulder in patients with diabetes mellitus. Am J Med. Apr 15 2002;112(6):487-90. [Medline].

  4. Carlsson A. Hereditary hemochromatosis: a neglected diagnosis in orthopedics: a series of 7 patients with ankle arthritis, and a review of the literature. Acta Orthop. Jun 2009;80(3):371-4. [Medline].

  5. Chew FS. Radiologic manifestations in the musculoskeletal system of miscellaneous endocrine disorders. Radiol Clin North Am. Jan 1991;29(1):135-47. [Medline].

  6. Crispin JC, Alcocer-Varela J. Rheumatologic manifestations of diabetes mellitus. Am J Med. Jun 15 2003;114(9):753-7. [Medline].

  7. Diamond T, Stiel D, Posen S. Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors?. Ann Intern Med. Mar 15 1989;110(6):430-6. [Medline].

  8. Dorwart BB, Schumacher HR. Joint effusions, chondrocalcinosis and other rheumatic manifestations in hypothyroidism. A clinicopathologic study. Am J Med. Dec 1975;59(6):780-90. [Medline].

  9. Faraawi R, Harth M, Kertesz A, Bell D. Arthritis in hemochromatosis. J Rheumatol. Mar 1993;20(3):448-52. [Medline].

  10. Golding DN. Rheumatism and the thyroid. J R Soc Med. Mar 1993;86(3):130-2. [Medline].

  11. Jacobs-Kosmin D, DeHoratius RJ. Musculoskeletal manifestations of endocrine disorders. Curr Opin Rheumatol. Jan 2005;17(1):64-9. [Medline].

  12. Jordan JM. Arthritis in hemochromatosis or iron storage disease. Curr Opin Rheumatol. Jan 2004;16(1):62-6. [Medline].

  13. Kaminski HJ. Endocrine myopathies. Myology. 1994: 1741-2.

  14. Kapur S, McKendry RJ. Treatment and outcomes of diabetic muscle infarction. J Clin Rheumatol. Feb 2005;11(1):8-12. [Medline].

  15. Khachadurian AK. Migratory polyarthritis in familial hypercholesterolemia (type II hyperlipoproteinemia). Arthritis Rheum. Jun 1968;11(3):385-93. [Medline].

  16. Klein I, Parker M, Shebert R, Ayyar DR, Levey GS. Hypothyroidism presenting as muscle stiffness and pseudohypertrophy: Hoffmann's syndrome. Am J Med. Apr 1981;70(4):891-4. [Medline].

  17. Klemp P, Halland AM, Majoos FL, Steyn K. Musculoskeletal manifestations in hyperlipidaemia: a controlled study. Ann Rheum Dis. Jan 1993;52(1):44-8. [Medline].

  18. Lacks S, Jacobs RP. Acromegalic arthropathy: a reversible rheumatic disease. J Rheumatol. Jun 1986;13(3):634-6. [Medline].

  19. Lieberman SA, Bjorkengren AG, Hoffman AR. Rheumatologic and skeletal changes in acromegaly. Endocrinol Metab Clin North Am. Sep 1992;21(3):615-31. [Medline].

  20. McLean RM, Podell DN. Bone and joint manifestations of hypothyroidism. Semin Arthritis Rheum. Feb 1995;24(4):282-90. [Medline].

  21. Olynyk J, Hall P, Ahern M, et al. Screening for genetic haemochromatosis in a rheumatology clinic. Aust N Z J Med. Feb 1994;24(1):22-5. [Medline].

  22. Pal B, Anderson J, Dick WC, Griffiths ID. Limitation of joint mobility and shoulder capsulitis in insulin- and non-insulin-dependent diabetes mellitus. Br J Rheumatol. May 1986;25(2):147-51. [Medline].

  23. Rimon D, Cohen L. Hypercholesterolemic (type II hyperlipoproteinemic) arthritis. J Rheumatol. May 1989;16(5):703-5. [Medline].

  24. Schumacher HR, Straka PC, Krikker MA, Dudley AT. The arthropathy of hemochromatosis. Recent studies. Ann N Y Acad Sci. 1988;526:224-33. [Medline].

  25. Smith LL, Burnet SP, McNeil JD. Musculoskeletal manifestations of diabetes mellitus. Br J Sports Med. Feb 2003;37(1):30-5. [Medline].

  26. Stevens JC, Beard CM, O'Fallon WM, Kurland LT. Conditions associated with carpal tunnel syndrome. Mayo Clin Proc. Jun 1992;67(6):541-8. [Medline].

Previous
Next
 
This picture shows a 42-year-old white man who was admitted with acute back pain. In this frontal view, note the lower-face fullness that obscures his ears and the plethora of his cheeks.
Focal osteolytic changes seen in the phalanges in a patient with chronic sarcoid arthritis.
Osteolysis has left a lacy trabecular pattern in this phalanx (arrow).
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.